Why Twist Bioscience Corporation [TWST] Stock Will Fly to $125.00 Over the Next 12 Months

Twist Bioscience Corporation [TWST] has traded in a range of $18.52 to $121.40 in the last 1 year. As of this writing, the stock is at $123.19, up 7.06%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, TWST shares are 10.46% up with the monthly amount drift of 44.98% and seems well in a long time frame.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


On 2, December 2020, Twist Bioscience Announces Pricing of a $300 Million Upsized Public Offering of Common Stock. According to news published on Yahoo Finance, Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 2,802,272 shares of its common stock at a price to the public of $110.00 per share, which consists of 2,727,272 shares to be sold by Twist and 75,000 shares to be sold by certain selling stockholders. The gross proceeds of the offering to Twist before deducting the underwriting discount and commissions and estimated offering expenses, and assuming no exercise of the underwriters’ option to purchase additional shares from the Company, are expected to be approximately $300 million. Twist has granted the underwriters a 30-day option to purchase up to an additional 409,090 shares of common stock at the public offering price, less the underwriting discount and commissions. The offering is expected to close on or about December 7, 2020, subject to the satisfaction of customary closing conditions. Twist will not receive any proceeds from the sale of common stock by the selling stockholders.

Analyst Birdseye View:

The most recent analyst activity for Twist Bioscience Corporation [NASDAQ:TWST] stock was on May 31, 2019, when it was Initiated with an Outperform rating from Evercore ISI. Before that, on October 20, 2020, SVB Leerink Recapitulated a Mkt perform rating and elevated its amount target to $90. On November 26, 2018, JP Morgan Initiated a Neutral rating and boosted its price target on this stock to $27.

In the past 52 weeks of trading, this stock has oscillated between a low of $18.52 and a peak of $121.40. Right now, the middling Wall Street analyst 12-month amount mark is $112.50. At the most recent market close, shares of Twist Bioscience Corporation [NASDAQ:TWST] were valued at $123.19. According to the average price forecast, investors can expect a potential return of 0.0%.


Twist Bioscience Corporation [NASDAQ:TWST] most recently reported quarterly sales of 32.43 billion, which represented growth of 55.90%. This publicly-traded organization’s revenue is $171,619 per employee, while its income is -$266,535 per employee. This company’s Gross Margin is currently 31.80%, its Pretax Margin is -154.88, and its Net Margin is -155.31. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -47.77, -57.31, -44.20 and -53.92 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 9.67 and the whole liability to whole assets at 9.02. It shows enduring liability to the whole principal at 7.05 and enduring liability to assets at 0.07 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 109.91 points at 1st support level, the second support level is making up to 104.76. But as of 1st resistance point, this stock is sitting at 118.83 and at 122.60 for 2nd resistance point.

Twist Bioscience Corporation [TWST] reported its earnings at -$0.54 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.7/share signifying the difference of 0.16 and 22.90% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.67 calling estimates for -$0.73/share with the difference of 0.06 depicting the surprise of 8.20%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Twist Bioscience Corporation [NASDAQ:TWST] is 11.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 8.05. Now if looking for a valuation of this stock’s amount to sales ratio it’s 33.04 and it’s amount to book ratio is 10.19.

Insider Stories

The most recent insider trade was by Banyai William, See Remarks, and it was the sale of 2790.0 shares on Nov 30. Weiss Patrick, the Chief Operating Officer, completed a sale of 3550.0 shares on Nov 13. On Nov 12, Weiss Patrick, Chief Operating Officer, completed a sale of 3550.0 shares.